{"id":"https://openalex.org/W4401669136","doi":"https://doi.org/10.5121/ijbb.2024.14302","title":"A Budget Impact Analysis of Adalimumab Biosimilars; The Albanian Context","display_name":"A Budget Impact Analysis of Adalimumab Biosimilars; The Albanian Context","publication_year":2024,"publication_date":"2024-08-17","ids":{"openalex":"https://openalex.org/W4401669136","doi":"https://doi.org/10.5121/ijbb.2024.14302"},"language":"en","primary_location":{"id":"doi:10.5121/ijbb.2024.14302","doi":"https://doi.org/10.5121/ijbb.2024.14302","is_oa":true,"landing_page_url":"http://doi.org/10.5121/ijbb.2024.14302","pdf_url":"http://dx.doi.org/10.5121/ijbb.2024.14302","source":{"id":"https://openalex.org/S4210194810","display_name":"International Journal on Bioinformatics & Biosciences","issn_l":"1839-9614","issn":["1839-9614"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal on Bioinformatics & Biosciences","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"http://dx.doi.org/10.5121/ijbb.2024.14302","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5106583309","display_name":"Dorela Hasankolli","orcid":"https://orcid.org/0009-0001-5124-8191","observed_orcids":["https://orcid.org/0009-0001-5124-8191"]},"institutions":[{"id":"https://openalex.org/I1283489935","display_name":"University of Medicine Tirana","ror":"https://ror.org/03y2x8717","country_code":"AL","type":"education","lineage":["https://openalex.org/I1283489935"]}],"countries":["AL"],"is_corresponding":false,"raw_author_name":"Dorela Hasankolli","raw_affiliation_strings":["Departament of Pharmacy, University of Medicine, Tirana, Albania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departament of Pharmacy, University of Medicine, Tirana, Albania","institution_ids":["https://openalex.org/I1283489935"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012099117","display_name":"Mirela Miraci","orcid":"https://orcid.org/0009-0003-4922-0223","observed_orcids":["https://orcid.org/0009-0003-4922-0223"]},"institutions":[{"id":"https://openalex.org/I1283489935","display_name":"University of Medicine Tirana","ror":"https://ror.org/03y2x8717","country_code":"AL","type":"education","lineage":["https://openalex.org/I1283489935"]}],"countries":["AL"],"is_corresponding":false,"raw_author_name":"Mirela Miraci","raw_affiliation_strings":["Departament of Pharmacy, University of Medicine, Tirana, Albania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departament of Pharmacy, University of Medicine, Tirana, Albania","institution_ids":["https://openalex.org/I1283489935"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062107070","display_name":"Teuta Backa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800414091","display_name":"Mother Teresa Hospital","ror":"https://ror.org/027x3m696","country_code":"AL","type":"healthcare","lineage":["https://openalex.org/I2800414091"]}],"countries":["AL"],"is_corresponding":false,"raw_author_name":"Teuta Backa","raw_affiliation_strings":["Department of Rheumatology, \"Mother Teresa\" University Medical Center, Tirana, Albania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rheumatology, \"Mother Teresa\" University Medical Center, Tirana, Albania","institution_ids":["https://openalex.org/I2800414091"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091438818","display_name":"Entela Halo\u00e7i","orcid":"https://orcid.org/0000-0003-2992-8307","observed_orcids":["https://orcid.org/0000-0003-2992-8307"]},"institutions":[{"id":"https://openalex.org/I1283489935","display_name":"University of Medicine Tirana","ror":"https://ror.org/03y2x8717","country_code":"AL","type":"education","lineage":["https://openalex.org/I1283489935"]}],"countries":["AL"],"is_corresponding":false,"raw_author_name":"Entela Halo\u00e7i","raw_affiliation_strings":["Departament of Pharmacy, University of Medicine, Tirana, Albania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departament of Pharmacy, University of Medicine, Tirana, Albania","institution_ids":["https://openalex.org/I1283489935"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.11799902,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"14","issue":"3","first_page":"11","last_page":"17"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.8192999958992004,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.8192999958992004,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.1680999994277954,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.010200000368058681,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adalimumab-biosimilar","display_name":"adalimumab biosimilar","score":0.9760000109672546},{"id":"https://openalex.org/keywords/budget-impact-analysis","display_name":"budget impact analysis","score":0.9210000038146973},{"id":"https://openalex.org/keywords/healthcare-cost-reduction","display_name":"healthcare cost reduction","score":0.6710000038146973},{"id":"https://openalex.org/keywords/autoimmune-disease","display_name":"autoimmune disease","score":0.8130000233650208},{"id":"https://openalex.org/keywords/tnf-alpha-inhibitors","display_name":"TNF-alpha inhibitors","score":0.9549999833106995},{"id":"https://openalex.org/keywords/treatment-access","display_name":"treatment access","score":0.5979999899864197}],"concepts":[{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.9064472317695618},{"id":"https://openalex.org/C2780132546","wikidata":"https://www.wikidata.org/wiki/Q348260","display_name":"Adalimumab","level":3,"score":0.8217960596084595},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.7126359939575195},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3529282212257385},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3491514325141907},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.212654709815979},{"id":"https://openalex.org/C95457728","wikidata":"https://www.wikidata.org/wiki/Q309","display_name":"History","level":0,"score":0.17211860418319702},{"id":"https://openalex.org/C166957645","wikidata":"https://www.wikidata.org/wiki/Q23498","display_name":"Archaeology","level":1,"score":0.0},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.5121/ijbb.2024.14302","doi":"https://doi.org/10.5121/ijbb.2024.14302","is_oa":true,"landing_page_url":"http://doi.org/10.5121/ijbb.2024.14302","pdf_url":"http://dx.doi.org/10.5121/ijbb.2024.14302","source":{"id":"https://openalex.org/S4210194810","display_name":"International Journal on Bioinformatics & Biosciences","issn_l":"1839-9614","issn":["1839-9614"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal on Bioinformatics & Biosciences","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.5121/ijbb.2024.14302","doi":"https://doi.org/10.5121/ijbb.2024.14302","is_oa":true,"landing_page_url":"http://doi.org/10.5121/ijbb.2024.14302","pdf_url":"http://dx.doi.org/10.5121/ijbb.2024.14302","source":{"id":"https://openalex.org/S4210194810","display_name":"International Journal on Bioinformatics & Biosciences","issn_l":"1839-9614","issn":["1839-9614"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal on Bioinformatics & Biosciences","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4401669136.pdf","grobid_xml":"https://content.openalex.org/works/W4401669136.grobid-xml"},"referenced_works_count":11,"referenced_works":["https://openalex.org/W2032836693","https://openalex.org/W2045200703","https://openalex.org/W2119679249","https://openalex.org/W2902437733","https://openalex.org/W2944641370","https://openalex.org/W3049020864","https://openalex.org/W3111948372","https://openalex.org/W3115637958","https://openalex.org/W4311482817","https://openalex.org/W4385368124","https://openalex.org/W4389486878"],"related_works":["https://openalex.org/W2944641370","https://openalex.org/W3111948372","https://openalex.org/W4240513502","https://openalex.org/W4232523074","https://openalex.org/W4236940839","https://openalex.org/W2727950574","https://openalex.org/W4401054500","https://openalex.org/W3139229399","https://openalex.org/W4231398342","https://openalex.org/W4240167399"],"abstract_inverted_index":{"Adalimumab":[0,22,30,102],"is":[1,23,47,83],"used":[2],"to":[3,35,48,55,74,79,203,230],"treat":[4],"various":[5],"autoimmune":[6,121,184],"conditions,":[7],"such":[8],"as":[9],"rheumatoid":[10],"arthritis,":[11,16],"ankylosing":[12],"spondylitis,":[13],"psoriasis,":[14],"psoriatic":[15],"Crohn\u2019s":[17],"disease,":[18],"and":[19,88,176],"ulcerative":[20],"colitis.":[21],"a":[24,50,84,147],"tumor":[25],"necrosis":[26],"factor":[27],"(TNF)":[28],"inhibitor.":[29],"biosimilars":[31,103],"have":[32,168,187,200],"the":[33,39,45,57,62,65,157,160,164,177,192,216],"potential":[34,58,193],"reduce":[36],"costs":[37],"for":[38,99,105,120,138,183,240],"healthcare":[40],"system.":[41],"The":[42,114,153,209,232],"aim":[43],"of":[44,61,64,70,108,117,159,173,180,218,226],"study":[46],"develop":[49],"drug":[51,110],"budget":[52,85],"impact":[53,60,86],"analysis":[54,87,154],"assess":[56],"financial":[59],"availability":[63,217],"biosimilar":[66,161,165],"adalimumab-aacf":[67,166,219],"in":[68,92,112,126,170,206,224,236],"terms":[69,225],"cost":[71,89,116,171,179,194,227],"savings":[72,172,228],"due":[73],"its":[75],"lower":[76,149],"price":[77,150],"compared":[78,229],"adalimumab-adaz.":[80,231],"Methods:":[81],"This":[82],"calculator":[90],"model":[91],"Microsoft":[93],"Excel":[94],"based":[95],"on":[96],"FDSKSH\u2019s":[97],"data":[98],"2023.":[100,113,207],"Results:":[101],"accounted":[104,137],"approximately":[106],"25%":[107],"biologic":[109,118,181,204],"prescriptions":[111],"reimbursement":[115,178],"drugs":[119,182,205],"diseases":[122,185],"was":[123,144],"ALL":[124,129,174],"186,523,409":[125],"2023":[127],"(1":[128],"=":[130],"0.01":[131],"USD).":[132],"Of":[133],"that":[134,156,215],"cost,":[135],"15.21%":[136],"treatment":[139,238],"with":[140,163],"adalimumab":[141],"biosimilars.":[142],"Adalimumab-aacf":[143],"available":[145],"at":[146],"15.82%":[148],"than":[151],"adalimumab\u2013adaz.":[152],"indicated":[155],"replacement":[158],"adalimumab-adaz":[162],"could":[167,186,199,234],"resulted":[169],"968,138,":[175],"been":[188],"3%":[189],"lower.":[190],"With":[191],"savings,":[195],"two":[196],"more":[197,222],"patients":[198],"had":[201],"access":[202,239],"Conclusions:":[208],"Drug":[210],"Budget":[211],"Impact":[212],"Analysis":[213],"estimated":[214],"would":[220],"be":[221],"profitable":[223],"scenario":[233],"result":[235],"increased":[237],"patients.":[241]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2024-08-18T00:00:00"}